E-mail: bd@sidmexinovia.com
Telefone: +918866862020
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Início >
Ricovir EM Tablet
Ricovir EM Tablet
Manufacturer/Marketed By : Mylan Pharmaceuticals Pvt Ltd
$23.23 $7.02
Ricovir EM Tablet is an effective antiretroviral treatment that combines emtricitabine and tenofovir disoproxil fumarate, specifically designed for adults and adolescents aged 12 years and above who weigh at least...
Emtricitabine 200 mg + Tenofovir disoproxil fumarate 300 mg
Active Pharmaceutical Ingredient
Ricovir EM Tablet
US$ 23,23
US$ 7,02
Ricovir EM Tablet is an effective antiretroviral treatment that combines emtricitabine and tenofovir disoproxil fumarate, specifically designed for adults and adolescents aged 12 years and above who weigh at least 35 kg and are living with Human Immunodeficiency Virus type 1 (HIV-1). This powerful medication works by inhibiting the replication of the virus, thereby helping to manage HIV infection and significantly reducing the risk of progression to acquired immunodeficiency syndrome (AIDS). When taken as prescribed, Ricovir EM can enhance the quality of life for those affected by HIV, but it's crucial to adhere to the treatment plan to achieve optimal results. Patients should be aware of potential side effects and discuss any pre-existing health conditions with their healthcare provider to ensure safe usage. Regular monitoring and follow-up appointments are essential to assess the effectiveness of the treatment and make any necessary adjustments. For those seeking a reliable solution in their fight against HIV, Ricovir EM Tablet offers a promising option. Always consult your healthcare professional before starting any new medication to ensure it's right for you.
Active Pharmaceutical Ingredient
Usos
• Ricovir em tablet is primarily used in the management of human immunodeficiency virus (HIV) infection. This medication plays a crucial role in suppressing viral replication, which helps to preserve the immune system's functionality. By reducing the viral load, Ricovir em tablet aids patients in maintaining a healthier immune response. This is essential for improving the quality of life in individuals living with HIV.
• In addition to treating HIV, Ricovir em tablet contributes to the long-term health of patients by preventing the progression to acquired immunodeficiency syndrome (AIDS). The timely use of this medication can significantly delay the onset of AIDS-related complications. By adhering to a treatment regimen that includes Ricovir em tablet, patients can better manage their health and reduce the risk of opportunistic infections. This proactive approach is vital for those diagnosed with HIV.
• Ricovir em tablet is also utilized in combination with other antiretroviral therapies to enhance treatment effectiveness. This multi-drug strategy is often necessary to combat the potential for viral resistance. Patients taking Ricovir em tablet as part of a comprehensive treatment plan can achieve better outcomes and improved viral suppression. Collaborative care with healthcare providers ensures optimal use of this medication for managing HIV.
• For individuals newly diagnosed with HIV, Ricovir em tablet may be recommended as part of their initial treatment regimen. Starting therapy early is essential for controlling the virus and maintaining immune health. By incorporating Ricovir em tablet into their daily routine, patients can take an active role in their treatment journey. This early intervention can lead to more favorable health results over time.
Benefícios
Anti-HIV Drug Ricovir EM is a combination of antiretroviral medicines that fights human immunodeficiency virus (HIV) infection by reducing the amount of the virus in the blood. It is used in antiretroviral combination therapy for the treatment of HIV infection. Emtricitabine + Tenofovir Tablet reduces the amount of HIV virus in your body and keeps it low. It also increases CD4 cell counts. CD4 cells are a type of white blood cell that plays an essential role in maintaining a healthy immune system to help fight infection. Response to treatment with Anti-HIV Drug Ricovir EM varies between patients. Your doctor or healthcare provider will be monitoring the effectiveness of your treatment. Ricovir EM Tablet may improve your condition, but it does not cure your HIV infection. HIV infection is a disease spread by contact with blood or sexual contact with an infected individual. Treatment with Ricovir EM Tablet has not been shown to eliminate the risk of passing HIV infection on to others by sexual contact or by blood transfer. Therefore, you must continue to take appropriate precautions to avoid giving the virus to others.
Efeitos colaterais
As with all medicines, Ricovir EM 200/300 mg Tablet may cause side effects that do not require medical attention and that will disappear as your body adjusts to the medicine. If they persist or you're concerned about them, tell your doctor.
Efeitos colaterais mais comuns
• Diarrhea
• Dizziness
• Fatigue
• Headache
• Nausea
• Rash
Efeitos colaterais comuns
• Depression
• Anxiety
• Loss in appetite
• Stomach pain
• Blood in urine
• Changes in the amount of urine
Como usar
Ricovir EM 200/300 mg Tablet can be taken with or without food. Swallow the tablet whole with a full glass of water. Do not crush, chew, or open the tablet. If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the next dose at the regular time. Do not take two doses at the same time to make up for a missed dose.
Conselhos de segurança
• Alcohol: It is generally not recommended to drink alcohol while taking Emtricitabine + Tenofovir Tablet. It may increase the risk of liver damage. It is best to avoid alcohol or limit your alcohol consumption while taking this medication.
• Kidney: Ricovir EM Tablet should be modified in HIV-infected adult patients with creatinine clearance of 30–49 mL/min. Anti-HIV Drug Ricovir EM should not be used in patients with creatinine clearance below 30 mL/min and in patients with end-stage renal disease requiring dialysis.
• Breastfeeding: Anti-HIV Drug Ricovir EM may pass into human milk. There is insufficient information on the effects of Emtricitabine + Tenofovir Tablet in newborns/infants. The use of Ricovir EM 200/300 mg Tablet should not be used during breastfeeding.
• Liver: Ricovir EM should be used with caution in patients with kidney disease. Dose adjustment of Ricovir EM may be needed. Please consult your doctor.
• Pregnancy: Ricovir EM Tablet may be considered safe to use in pregnant women. There are no malformations or foetal/neonatal toxicity associated with Ricovir EM Tablet. Therefore the use of Ricovir EM Tablet may be considered during pregnancy, if necessary.
• Driving: Ricovir EM Tablet may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions, such as avoiding driving a vehicle or operating heavy machinery, if you suffer from the side effects of this Emtricitabine + Tenofovir Tablet.
Isenção de responsabilidade
A Sidmex Inovia se esforça para fornecer informações precisas e confiáveis; no entanto, todo o conteúdo deste site, incluindo descrições e composições de produtos, tem caráter meramente informativo e não deve ser considerado um substituto para aconselhamento, diagnóstico ou tratamento médico profissional.
Recomenda-se aos usuários que consultem um profissional de saúde qualificado antes de tomar qualquer decisão médica. As informações fornecidas não devem ser usadas para autodiagnóstico ou automedicação.
Todos os produtos listados destinam-se estritamente a consultas B2B e em grandes quantidades. A Sidmex Inovia não promove o uso direto pelo consumidor e visa apoiar, e não substituir, a relação entre o profissional de saúde e o paciente.
Os nomes de produtos, marcas comerciais e marcas pertencem aos seus respectivos proprietários, e seu uso não implica qualquer afiliação ou endosso. A Sidmex Inovia não se responsabiliza por quaisquer consequências decorrentes do uso das informações fornecidas neste site.



